Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis.
AUTOR(ES)
Schmutzhard, E
RESUMO
Sera of 106 multiple sclerosis patients and 103 closely matched controls were examined for Borrelia burgdorferi antibodies. The prevalence rate in multiple sclerosis patients was 14.2%, in controls 25.2%. Overall prevalence was 20.1%. Mean IgG antibody level was insignificantly higher in controls than in multiple sclerosis patients. Patients with a chronic progressive course of multiple sclerosis had an insignificantly higher mean borrelia antibody level, when compared with those suffering from relapsing/remitting form of disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1033030Documentos Relacionados
- Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.
- Postural Control in Relapsing-Remitting Multiple Sclerosis
- Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.
- Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
- Stressful events increase exacerbations in relapsing-remitting multiple sclerosis